Glycosaminoglycan turn-over in articular cartilage
- PMID: 239424
- DOI: 10.1098/rstb.1975.0054
Glycosaminoglycan turn-over in articular cartilage
Abstract
Glycosaminoglycan turn-over has been studied both in vivo and in vitro, by using sodium [35S]sulphate as a precursor. The in vivo experiments were performed on rabbits and dogs, taking special care to monitor the 35S radioactivity in the serum throughout the experiment and to measure the radioactivity due to unincorporated inorganic [35S]sulphate in cartilage at the end of each experiment, in addition to that due to incorporated sulphate. The inorganic sulphate content of the serum was also determined as well as the distribution coefficient for the inorganic sulphate ion between cartilage and serum. From this information it was possible to calculate accurately the rate of sulphate uptake by cartilage in vivo and hence the turn-over rate. Experiments were then performed in vitro on cartilage from rabbits and dogs and the in vivo and in vitro results were compared. A very good agreement was obtained between the two sets of results. Studies were then carried out under exactly the same in vitro conditions on human articular cartilage and it was thus possible to obtain a turn-over rate for the latter which one could trust was close to the actual in vivo value. The mean half-lives thus obtained varied from 45 days for the young rabbit to 150 days for the adult dog and 800 days for the human femoral head. In human cartilage there were considerable variations in turn-over rate within a single joint as a function of depth below the surface, and between different joints. Thus, while the mean half-life for the human femoral head is 800 days, that for the femoral condyle is 300 days. Cartilage from osteoarthrosic femoral heads did not appear to differ much with respect to sulphate uptake from the normal specimens although the turn-over rates were somewhat higher.
Similar articles
-
Studies on the in vitro incubation procedure for [35S]sulphate labelling of articular cartilage glycosaminoglycans.Biochim Biophys Acta. 1977 Feb 28;496(2):420-30. doi: 10.1016/0304-4165(77)90324-5. Biochim Biophys Acta. 1977. PMID: 556961
-
Changes in cartilage proteoglycan aggrecan after intra-articular injection of interleukin-1 in rabbits: studies of synovial fluid and articular cartilage.Ann Rheum Dis. 1996 Aug;55(8):525-34. doi: 10.1136/ard.55.8.525. Ann Rheum Dis. 1996. PMID: 8774180 Free PMC article.
-
Glycosaminoglycan content and cell density of rabbit articular cartilage in experimental lipoarthrosis.J Anat. 1981 Sep;133(Pt 2):309-15. J Anat. 1981. PMID: 6800995 Free PMC article.
-
Changes in chondroitin sulphate structure induced by joint disease.Acta Orthop Scand Suppl. 1995 Oct;266:107-10. Acta Orthop Scand Suppl. 1995. PMID: 8553837 Review. No abstract available.
-
[Serum keratan sulfate studies and their significance in the evaluation of cartilage degradation in degenerative and inflammatory joint diseases].Orv Hetil. 1993 Feb 28;134(9):461-7. Orv Hetil. 1993. PMID: 8446416 Review. Hungarian.
Cited by
-
Articular cartilage and osteoarthrosis. The role of molecular markers to monitor breakdown, repair and disease.J Anat. 1994 Jun;184 ( Pt 3)(Pt 3):477-92. J Anat. 1994. PMID: 7928637 Free PMC article. Review. No abstract available.
-
Metabolic responses of cartilage in experimentally induced osteoarthritis.Ann Rheum Dis. 1981 Dec;40(6):584-92. doi: 10.1136/ard.40.6.584. Ann Rheum Dis. 1981. PMID: 7332379 Free PMC article.
-
Metabolism of human femoral head cartilage in osteoarthrosis and subcapital fracture.Ann Rheum Dis. 1981 Feb;40(1):18-26. doi: 10.1136/ard.40.1.18. Ann Rheum Dis. 1981. PMID: 7469522 Free PMC article.
-
A stable isotope method for the simultaneous measurement of matrix synthesis and cell proliferation in articular cartilage in vivo.Osteoarthritis Cartilage. 2009 Jul;17(7):923-32. doi: 10.1016/j.joca.2009.01.006. Epub 2009 Feb 7. Osteoarthritis Cartilage. 2009. PMID: 19230856 Free PMC article.
-
Proteoglycan metabolism in isolated chondrocytes from human cartilage. Influence of niflumic acid.Clin Rheumatol. 1990 Mar;9(1):32-41. doi: 10.1007/BF02030238. Clin Rheumatol. 1990. PMID: 2335050
MeSH terms
Substances
LinkOut - more resources
Full Text Sources